The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective studyFrancesco Salerno, Mauro Borzio, Claudia Pedicino et al.|Liver International|2016Cited by 76
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir among 723 Italian patients with chronic hepatitis C: The Navigator-II studyRoberta D’Ambrosio, S. Fagiuoli, Barbara Menzaghi et al.|Journal of Hepatology|2018Cited by 12
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV‐infected patients treated in a real‐life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri et al.|Journal of Viral Hepatitis|2020Cited by 12
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life studyNicola Pugliese, Alessio Aghemo, Alessia Giorgini et al.|Expert Opinion on Drug Safety|2021Cited by 6